Advate / Rixubis - direct healthcare professional communication (DHPC)

Octocog alfa / Factor VIII Inhibitor Bypassing Activity / Nonacog gamma
DHPCHuman

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

  • Advate
  • Rixubis
Active substance
  • Octocog alfa
  • Factor VIII Inhibitor Bypassing Activity
  • Nonacog gamma
Regulatory outcome
Variation
DHPC type
Quality defect
Dissemination date

Share this page